The Clorox Company (FRA:CXX)
Germany · Delayed Price · Currency is EUR 111.00
+1.00 (0.91%)
Last updated: Jul 30, 2025
Inozyme Pharma Cash Flow Statement
Financials in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | 2016 - 2020 |
Net Income | - | 280 | 149 | 462 | 710 | Upgrade |
Depreciation & Amortization | - | 225 | 226 | 216 | 205 | Upgrade |
Other Amortization | - | 10 | 10 | 8 | 6 | Upgrade |
Loss (Gain) From Sale of Assets | - | 238 | - | - | - | Upgrade |
Asset Writedown & Restructuring Costs | - | - | 445 | - | 329 | Upgrade |
Stock-Based Compensation | - | 74 | 73 | 52 | 50 | Upgrade |
Other Operating Activities | - | 109 | -99 | 147 | -13 | Upgrade |
Change in Accounts Receivable | - | -34 | -13 | -84 | 82 | Upgrade |
Change in Inventory | - | 55 | 58 | -18 | -282 | Upgrade |
Change in Accounts Payable | - | -140 | 157 | -47 | 311 | Upgrade |
Change in Income Taxes | - | -147 | 152 | 35 | -90 | Upgrade |
Change in Other Net Operating Assets | - | 25 | - | 15 | -32 | Upgrade |
Operating Cash Flow | - | 695 | 1,158 | 786 | 1,276 | Upgrade |
Operating Cash Flow Growth | - | -39.98% | 47.33% | -38.40% | -17.46% | Upgrade |
Capital Expenditures | - | -212 | -228 | -251 | -331 | Upgrade |
Cash Acquisitions | - | - | - | - | -85 | Upgrade |
Divestitures | - | 17 | - | - | - | Upgrade |
Other Investing Activities | - | 20 | 5 | 22 | -36 | Upgrade |
Investing Cash Flow | - | -175 | -223 | -229 | -452 | Upgrade |
Short-Term Debt Issued | - | - | - | 237 | - | Upgrade |
Long-Term Debt Issued | - | - | - | 1,085 | - | Upgrade |
Total Debt Issued | - | - | - | 1,322 | - | Upgrade |
Short-Term Debt Repaid | - | -45 | -188 | - | - | Upgrade |
Long-Term Debt Repaid | - | - | - | -1,405 | - | Upgrade |
Total Debt Repaid | - | -45 | -188 | -1,405 | - | Upgrade |
Net Debt Issued (Repaid) | - | -45 | -188 | -83 | - | Upgrade |
Issuance of Common Stock | - | 1 | 33 | 5 | 103 | Upgrade |
Repurchase of Common Stock | - | - | - | -25 | -905 | Upgrade |
Common Dividends Paid | - | -595 | -583 | -571 | -558 | Upgrade |
Other Financing Activities | - | -16 | -15 | -15 | -31 | Upgrade |
Financing Cash Flow | - | -655 | -753 | -689 | -1,391 | Upgrade |
Foreign Exchange Rate Adjustments | - | -26 | - | -6 | 12 | Upgrade |
Net Cash Flow | - | -161 | 182 | -138 | -555 | Upgrade |
Free Cash Flow | - | 483 | 930 | 535 | 945 | Upgrade |
Free Cash Flow Growth | - | -48.07% | 73.83% | -43.39% | -26.86% | Upgrade |
Free Cash Flow Margin | - | 6.81% | 12.59% | 7.53% | 12.87% | Upgrade |
Free Cash Flow Per Share | - | 3.87 | 7.49 | 4.32 | 7.42 | Upgrade |
Cash Interest Paid | - | 102 | 99 | 89 | 89 | Upgrade |
Cash Income Tax Paid | - | 347 | 73 | 100 | 303 | Upgrade |
Levered Free Cash Flow | - | 359.38 | 921.25 | 164.75 | 595.13 | Upgrade |
Unlevered Free Cash Flow | - | 415.63 | 977.5 | 231 | 657 | Upgrade |
Change in Net Working Capital | -334 | 257 | -389 | 239 | 43 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.